ES8607018A1 - Preparaciones medicinales solidas - Google Patents

Preparaciones medicinales solidas

Info

Publication number
ES8607018A1
ES8607018A1 ES544787A ES544787A ES8607018A1 ES 8607018 A1 ES8607018 A1 ES 8607018A1 ES 544787 A ES544787 A ES 544787A ES 544787 A ES544787 A ES 544787A ES 8607018 A1 ES8607018 A1 ES 8607018A1
Authority
ES
Spain
Prior art keywords
pvp
granulate
manufacture
pharmaceutical preparations
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544787A
Other languages
English (en)
Spanish (es)
Other versions
ES544787A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6239792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8607018(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES544787A0 publication Critical patent/ES544787A0/es
Publication of ES8607018A1 publication Critical patent/ES8607018A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Jellies, Jams, And Syrups (AREA)
ES544787A 1984-07-04 1985-07-02 Preparaciones medicinales solidas Expired ES8607018A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843424553 DE3424553A1 (de) 1984-07-04 1984-07-04 Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES544787A0 ES544787A0 (es) 1986-06-16
ES8607018A1 true ES8607018A1 (es) 1986-06-16

Family

ID=6239792

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544787A Expired ES8607018A1 (es) 1984-07-04 1985-07-02 Preparaciones medicinales solidas

Country Status (15)

Country Link
EP (1) EP0167909B2 (enExample)
JP (1) JPH0665644B2 (enExample)
KR (1) KR920006908B1 (enExample)
AT (1) ATE71297T1 (enExample)
AU (1) AU570328B2 (enExample)
CA (1) CA1255597A (enExample)
DE (2) DE3424553A1 (enExample)
DK (1) DK304485A (enExample)
ES (1) ES8607018A1 (enExample)
FI (1) FI852610L (enExample)
GR (1) GR851617B (enExample)
HU (1) HU197844B (enExample)
IL (1) IL75686A (enExample)
PT (1) PT80752B (enExample)
ZA (1) ZA855017B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133230A1 (es) * 1996-01-19 1999-09-01 Falicman Pablo Alber Rachitzky Composicion de absorcion programada de granulos.

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
US5015479A (en) * 1987-02-02 1991-05-14 Seamus Mulligan Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
JP4065321B2 (ja) * 1995-03-29 2008-03-26 塩野義製薬株式会社 水分活性を調節したゼラチンカプセル剤
EP1364643A4 (en) 2000-12-01 2009-07-15 Kyowa Hakko Kogyo Kk COMPOSITION WITH IMPROVED SOLUBILITY OR ORAL ABSORBIBILITY
DE10117049A1 (de) * 2001-04-05 2002-10-17 Novartis Ag Zusammensetzung
JP5072748B2 (ja) * 2007-07-10 2012-11-14 株式会社 メドレックス アムロジピンの安定な液剤とゼリー剤
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2133230A1 (es) * 1996-01-19 1999-09-01 Falicman Pablo Alber Rachitzky Composicion de absorcion programada de granulos.

Also Published As

Publication number Publication date
FI852610A0 (fi) 1985-07-02
JPS6118725A (ja) 1986-01-27
PT80752A (en) 1985-08-01
FI852610A7 (fi) 1986-01-05
CA1255597A (en) 1989-06-13
HUT41259A (en) 1987-04-28
AU4429885A (en) 1986-01-09
AU570328B2 (en) 1988-03-10
FI852610L (fi) 1986-01-05
DE3585107D1 (de) 1992-02-20
KR860000864A (ko) 1986-02-20
IL75686A0 (en) 1985-11-29
DK304485D0 (da) 1985-07-03
JPH0665644B2 (ja) 1994-08-24
KR920006908B1 (ko) 1992-08-22
EP0167909A3 (en) 1987-10-14
EP0167909B2 (de) 1994-10-19
IL75686A (en) 1988-11-30
DE3424553A1 (de) 1986-01-09
HU197844B (en) 1989-06-28
PT80752B (pt) 1987-10-20
GR851617B (enExample) 1985-11-26
EP0167909A2 (de) 1986-01-15
EP0167909B1 (de) 1992-01-08
ES544787A0 (es) 1986-06-16
ATE71297T1 (de) 1992-01-15
ZA855017B (en) 1986-02-26
DK304485A (da) 1986-01-05

Similar Documents

Publication Publication Date Title
ES8607018A1 (es) Preparaciones medicinales solidas
ES8305330A1 (es) Un procedimiento para la preparacion de 1,-4dihidropiridinas.
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
ES2086371T3 (es) 1,3-oxatiolanos sustituidos con propiedades antiviricas.
HUT61777A (en) Process for producing pyrimidine-nukleozides and pharmaceutical compositions containing them as active components
HUT59092A (en) Process for producing serotonine 5ht la agonists and pharmaceutical preparations containing said compounds as active substance
DE602005013248D1 (de) Amidderivate von 3-phenyldihydropyrimidoä4,5-düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel
ES8705856A1 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
GB8919417D0 (en) Novel compounds
OA09477A (fr) "Nouveaux dérivés de la napht-1-yl pipérazine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
FR2667068B1 (fr) Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES8504126A1 (es) Un procedimiento para la preparacion de 1,4-dihidropiridina
Wasson et al. . beta.-Adrenergic blocking agents. 3-(3-Substituted-amino-2-hydroxypropoxy)-4-substituted-1, 2, 5-thiadiazoles
CA2094703A1 (en) Substituted piperazines as central nervous system agents
PT87770A (pt) Process for the preparation of indolinone replaced by products
FR2669029B1 (fr) Nouveaux derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
YU218190A (sh) Derivati glutarne kiseline i njihovo dobijanje
FI93210B (fi) Menetelmä virusvastaisen yhdisteen valmistamiseksi
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
FR2679907B1 (fr) Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2766487B1 (fr) Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US4193928A (en) Lasalocid derivatives
FR2707984B1 (fr) Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20021003